Roberta Muni

Roberta Muni

Auto-generated profile, based on publicly available information

Roberta Muni

Ospedale Sant’Andrea

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
Giuseppe MinnitiGiuseppe Minniti
Giuseppe Minniti
DADante Amelio
Dante Amelio
MAMaurizio Amichetti
Maurizio Amichetti
MSMaurizio Salvati
Maurizio Salvati
RMRoberta Muni
Roberta Muni
RERiccardo Maurizi Enrici
Riccardo Maurizi Enrici

5 February 2008 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
Giuseppe MinnitiGiuseppe Minniti
Giuseppe Minniti
VSV. De Sanctis
V. De Sanctis
RMR. Muni
R. Muni
FFF. Filippone
F. Filippone
ABA. Bozzao
A. Bozzao
RER. Maurizi Enrici
R. Maurizi Enrici

29 August 2008 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
Giuseppe MinnitiGiuseppe Minniti
Giuseppe Minniti
VSV. De Sanctis
V. De Sanctis
RMR. Muni
R. Muni
DRD. Rasio
D. Rasio
GLG. Lanzetta
G. Lanzetta
RER. Maurizi Enrici
R. Maurizi Enrici

1 December 2009
Verified
Journal Article
Closed access
Giuseppe MinnitiGiuseppe Minniti
Giuseppe Minniti
RMR Muni
R Muni
GLG Lanzetta
G Lanzetta
PMP Marchetti
P Marchetti
RER Maurizi Enrici
R Maurizi Enrici

29 January 2010 in Tumori Journal
Verified
Journal Article
Closed access
PDF file
RMRoberta Muni
Roberta Muni
GMGiuseppe Minniti
Giuseppe Minniti
GLGaetano Lanzetta
Gaetano Lanzetta
PCPaola Caporello
Paola Caporello
AFAlessandro Frati
Alessandro Frati
RERiccardo Maurizi Enrici
Riccardo Maurizi Enrici
Objectives: The optimal treatment for patients with glioblastoma with unfavorable prognostic factors, such as old age and low performance status, remains controversial. We conducted a prospective study to assess the effect of temozolomide and short-course radiation versus short-course radiation alone in the treatment of poor-prognosis patients with newly diagnosed glioblastoma. Patients and methods: Forty-five patients with a newly diagnosed glioblastoma, older than 70 years or aged 50–70 years and with a Karnofsky performance score ≤70 were enrolled in this prospective study. Twenty-three patients were treated with an abbreviated course of radiotherapy (30 Gy in 6 fractions over 2 weeks) and 22 patients with the same radiotherapy schedule plus adjuvant temozolomide at the dose of 150–200 mg/m2 for 5 days every 28-day cycle. The primary end point was overall survival. Secondary end points included progression-free survival and toxicity. Results: Median overall survival was 7.3 months in the radiotherapy group and 9.4 months in the radiotherapy plus temozolomide group (P = 0.003), with respective 6-month overall survivals of 78% and 95%, respectively. Median progression-free survival was 4.4 months in the radiotherapy group and 5.5 months in the radiotherapy plus temozolomide group (P = 0.01), and respective 6-month progression-free survival rates were 22% and 45%. In multivariate analysis, Karnofsky performance score was the only significant independent predictive factor of survival (P = 0.03). Adverse effects of radiotherapy were mainly represented by neurotoxicity (24%), which resolved in most cases with the use of steroids. Grade 3-4 hematologic toxicity occurred in 36% of patients treated with temozolomide. Conclusions: The addition of temozolomide to short-term radiotherapy resulted in a statistically significant survival benefit with minimal additional toxicity in poor-prognosis patients with newly diagnosed glioblastoma. Future studies need to define the best combined regimens of radiotherapy and temozolomide on survival and quality of life in this subgroup of patients.

1 November 2012 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
VSVitaliana De Sanctis
Vitaliana De Sanctis
FFFrancesco Romeo Filippone
Francesco Romeo Filippone
MAMarco Alfò
Marco Alfò
RMRoberta Muni
Roberta Muni
ECElena Cavalieri
Elena Cavalieri
RERiccardo Maurizi Enrici
Riccardo Maurizi Enrici